180 related articles for article (PubMed ID: 3290110)
1. Pathogen specificity of Treponema pallidum subsp. pallidum integral membrane proteins identified by phase partitioning with Triton X-114.
Radolf JD; Norgard MV
Infect Immun; 1988 Jul; 56(7):1825-8. PubMed ID: 3290110
[TBL] [Abstract][Full Text] [Related]
2. Identification and localization of integral membrane proteins of virulent Treponema pallidum subsp. pallidum by phase partitioning with the nonionic detergent triton X-114.
Radolf JD; Chamberlain NR; Clausell A; Norgard MV
Infect Immun; 1988 Feb; 56(2):490-8. PubMed ID: 3276627
[TBL] [Abstract][Full Text] [Related]
3. Molecular cloning and characterization of the 15-kilodalton major immunogen of Treponema pallidum.
Purcell BK; Chamberlain NR; Goldberg MS; Andrews LP; Robinson EJ; Norgard MV; Radolf JD
Infect Immun; 1989 Dec; 57(12):3708-14. PubMed ID: 2680978
[TBL] [Abstract][Full Text] [Related]
4. Isolation of integral membrane proteins by phase partitioning with Triton X-114.
Brusca JS; Radolf JD
Methods Enzymol; 1994; 228():182-93. PubMed ID: 8047007
[No Abstract] [Full Text] [Related]
5. Antigenic relatedness and N-terminal sequence homology define two classes of periplasmic flagellar proteins of Treponema pallidum subsp. pallidum and Treponema phagedenis.
Norris SJ; Charon NW; Cook RG; Fuentes MD; Limberger RJ
J Bacteriol; 1988 Sep; 170(9):4072-82. PubMed ID: 3045083
[TBL] [Abstract][Full Text] [Related]
6. Antigenic interrelationship between endoflagella of Treponema phagedenis biotype Reiter and Treponema pallidum (Nichols): molecular characterization of endoflagellar proteins.
Radolf JD; Blanco DR; Miller JN; Lovett MA
Infect Immun; 1986 Dec; 54(3):626-34. PubMed ID: 2430886
[TBL] [Abstract][Full Text] [Related]
7. Identification of Treponema pallidum antigens: comparison with a nonpathogenic treponeme.
Lukehart SA; Baker-Zander SA; Gubish ER
J Immunol; 1982 Aug; 129(2):833-8. PubMed ID: 6177786
[TBL] [Abstract][Full Text] [Related]
8. Penicillin-binding proteins and peptidoglycan of Treponema pallidum subsp. pallidum.
Radolf JD; Moomaw C; Slaughter CA; Norgard MV
Infect Immun; 1989 Apr; 57(4):1248-54. PubMed ID: 2647634
[TBL] [Abstract][Full Text] [Related]
9. Genetic and physicochemical characterization of the recombinant DNA-derived 47-kilodalton surface immunogen of Treponema pallidum subsp. pallidum.
Chamberlain NR; Radolf JD; Hsu PL; Sell S; Norgard MV
Infect Immun; 1988 Jan; 56(1):71-8. PubMed ID: 3275588
[TBL] [Abstract][Full Text] [Related]
10. Identification of glycosylated protein antigens of Treponema pallidum and Treponema phagedenis.
Moskophidis M; Müller F
Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Jul; 259(4):468-76. PubMed ID: 3901616
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of glycoprotein antigens on surface of Treponema pallidum: comparison with nonpathogenic Treponema phagedenis biotype Reiter.
Moskophidis M; Müller F
Infect Immun; 1984 Dec; 46(3):867-9. PubMed ID: 6389370
[TBL] [Abstract][Full Text] [Related]
12. Extensive cross reactivity between Treponema pallidum and cultivable treponemes demonstrated by sequential immunoadsorption.
Wos SM; Wicher K
Int Arch Allergy Appl Immunol; 1986; 79(3):282-5. PubMed ID: 3512456
[TBL] [Abstract][Full Text] [Related]
13. Major integral membrane protein immunogens of Treponema pallidum are proteolipids.
Chamberlain NR; Brandt ME; Erwin AL; Radolf JD; Norgard MV
Infect Immun; 1989 Sep; 57(9):2872-7. PubMed ID: 2668191
[TBL] [Abstract][Full Text] [Related]
14. Characterization of monoclonal antibodies to Treponema pallidum.
Lukehart SA; Tam MR; Hom J; Baker-Zander SA; Holmes KK; Nowinski RC
J Immunol; 1985 Jan; 134(1):585-92. PubMed ID: 3880576
[TBL] [Abstract][Full Text] [Related]
15. Identification of T. pallidum polypeptides: a comparative study between the protein profiles of in vitro cultivated and in vivo propagated Treponema pallidum subsp. pallidum by two-dimensional polyacrylamide gel electrophoresis.
Altaie SS; Cox DL
Appl Theor Electrophor; 1991; 1(6):291-304. PubMed ID: 1932199
[TBL] [Abstract][Full Text] [Related]
16. Molecular specificities of monoclonal antibodies directed against virulent Treponema pallidum.
Marchitto KS; Selland-Grossling CK; Norgard MV
Infect Immun; 1986 Jan; 51(1):168-76. PubMed ID: 3510168
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the low-molecular-mass proteins of virulent Treponema pallidum.
Stamm LV; Parrish EA
Infect Immun; 1994 Jan; 62(1):271-9. PubMed ID: 8262639
[TBL] [Abstract][Full Text] [Related]
18. Comparison of major protein antigens and protein profiles of Treponema pallidum and Treponema pertenue.
Thornburg RW; Baseman JB
Infect Immun; 1983 Nov; 42(2):623-7. PubMed ID: 6358027
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody with hemagglutination, immobilization, and neutralization activities defines an immunodominant, 47,000 mol wt, surface-exposed immunogen of Treponema pallidum (Nichols).
Jones SA; Marchitto KS; Miller JN; Norgard MV
J Exp Med; 1984 Nov; 160(5):1404-20. PubMed ID: 6208310
[TBL] [Abstract][Full Text] [Related]
20. Correlation of treponemicidal activity in normal human serum with the presence of IgG antibody directed against polypeptides of Treponema phagedenis biotype Reiter and Treponema pallidum, Nichols strain.
Blanco DR; Radolf JD; Lovett MA; Miller JN
J Immunol; 1986 Sep; 137(6):2031-6. PubMed ID: 3528292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
